Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2008-5-26
pubmed:abstractText
Completing a long-lasting research on 1,3-oxathiolane muscarinic ligands, we have synthesized a set of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide derivatives, containing three or four stereogenic centers. In general the compounds are very potent antagonists even if, unlike the corresponding agonists, they show modest subtype selectivity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1464-3391
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5490-500
pubmed:meshHeading
pubmed-meshheading:18455407-Animals, pubmed-meshheading:18455407-Binding Sites, pubmed-meshheading:18455407-CHO Cells, pubmed-meshheading:18455407-Cells, Cultured, pubmed-meshheading:18455407-Cricetinae, pubmed-meshheading:18455407-Cricetulus, pubmed-meshheading:18455407-Dose-Response Relationship, Drug, pubmed-meshheading:18455407-Guinea Pigs, pubmed-meshheading:18455407-Ligands, pubmed-meshheading:18455407-Male, pubmed-meshheading:18455407-Models, Molecular, pubmed-meshheading:18455407-Molecular Structure, pubmed-meshheading:18455407-Muscarinic Antagonists, pubmed-meshheading:18455407-Pyrrolidines, pubmed-meshheading:18455407-Rabbits, pubmed-meshheading:18455407-Receptors, Muscarinic, pubmed-meshheading:18455407-Stereoisomerism, pubmed-meshheading:18455407-Structure-Activity Relationship, pubmed-meshheading:18455407-Sulfoxides
pubmed:year
2008
pubmed:articleTitle
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.
pubmed:affiliation
Laboratorio di Progettazione, Sintesi e Studio di Eterocicli Biologicamente Attivi (HeteroBioLab), Dipartimento di Scienze Farmaceutiche, Università di Firenze, Via U. Schiff 6, 50019 Sesto Fiorentino (FI), Italy. silvia.dei@unifi.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't